QLS5212

· Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QLS5212, covering 2026-03-12 to 2026-03-12. Get the full timeline:

Most recent: Clinical Trial Update: QLS5212 for Participants With Advanced Solid Tumors [Phase 1]